Effects of aspirin on platelet aggregation in smokers and nonsmokers

Annals of Pharmacotherapy

Volumn 31, Issue 3, 1997, Pages 290-293

  Chant, Clarence ^a   Fagan, Susan C ^a,b   Aurora, Sheena K ^a   Gidal, Barry E ^c   Joseph, Rajiv ^a  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE;

ADULT; ARTICLE; CAPILLARY RESISTANCE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SMOKING; THROMBOCYTE AGGREGATION INHIBITION; THROMBOEMBOLISM;

EID: 0031059265     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100303     Document Type: Article

References (16)

1. Levine PH. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation 1973;48:619-23.
2. FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J 1988;115:267-71.
3. Levine RL, Folts JD. Acute platelet thrombus formation in stenosed monkey carotid arteries: effects of ASA, sulfmpyrazone, epinephrine, smoking (abstract). Stroke 1988;19:134.
4. Davis JW, Hartman CR, Lewis HD Jr, Shelton L, Eigenberg DA, Hassanein KM, et al. Cigarette smoking-induced enhancement of platelet function: lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 1985;105:479-83.
5. Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Anderson S, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-7.
6. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;1:1215-20.
7. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
8. Belch JJF, McArdle BM, Burns P, Löwe GDO, Forbes CD. The effects of acute smoking on platelet behavior, fibrinolysis and haemorheology in habitual smokers. Thromb Haemostas 1984;51:6-8.
9. Renaud S, Blache D, Dumont E, Thevenon C, Wissendanger T. Platelet function after cigarette smoking in relation to nicotine and carbon monoxide. Clin Pharmacol Ther 1984;36:389-95.
10. Mackie IJ, Jones R, Machin SJ. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. J Clin Pathol 1984;37:874-8.
11. Taylor RR, Sturm M, Vandongen R, Strophair J, Beilin LJ. Whole blood platelet aggregation is not affected by cigarette smoking but is sex-related. Clin Exp Pharmacol Physiol 1987;14:665-71.
12. Foo LC, Roshidah I, Aimy MB. Platelets of habitual smokers have reduced susceptibility to aggregating agent. Thromb Haemostas 1991;65:317-9.
13. Davis JW, Arnold J. Time course of some effects of cigarette smoking on platelets. J Int Med 1992;231:31-6.
14. Sherman DG, Dyken ML, Gent M, Harrison MJG, Hart RG, Mohr JP. Antithrombotic therapy for cerebrovascular disorders: an update. Chest 1995;108(suppl):444S-56S.
15. Barnett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995;332:238-48.
16. Komiya T, Kudo M, Urabe T, Mizuno Y. Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease: assessment by platelet aggregation testing. Stroke 1994;25:2337-42.